Huabin Hu Selected Research

Huabin Hu Research Topics

Disease

20	Neoplasms (Cancer) 04/2024 - 06/2013
13	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 10/2013
8	Rectal Neoplasms (Rectal Cancer) 01/2023 - 01/2016
5	Neoplasm Metastasis (Metastasis) 02/2022 - 12/2017
4	Pathologic Complete Response 04/2024 - 11/2018
3	Microsatellite Instability 12/2023 - 01/2022
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 12/2019
2	Colonic Neoplasms (Colon Cancer) 04/2024 - 01/2020
2	Fistula 01/2023 - 01/2022
2	Mucinous Adenocarcinoma (Mucinous Carcinoma) 10/2022 - 12/2021
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2021 - 01/2021
2	Fatigue 10/2020 - 09/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2018 - 01/2017
2	Inflammation (Inflammations) 12/2018 - 01/2017
2	Stomach Neoplasms (Stomach Cancer) 12/2017 - 06/2013
1	Kidney Calculi (Kidney Stone) 04/2024
1	Urolithiasis 04/2024
1	Lymphatic Metastasis 04/2024
1	Prostatic Neoplasms (Prostate Cancer) 02/2024
1	Parkinson Disease (Parkinson's Disease) 02/2024
1	Turcot syndrome 10/2023
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 02/2023
1	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2022
1	Dyspepsia (Indigestion) 07/2022
1	Flushing 07/2022
1	Nausea 07/2022
1	Vomiting 07/2022
1	Sarcoma (Soft Tissue Sarcoma) 02/2022
1	Adenocarcinoma 12/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Neutropenia 10/2020
1	Breast Neoplasms (Breast Cancer) 06/2019
1	Disease Progression 06/2019
1	Hypersensitivity (Allergy) 09/2018
1	Intestinal Perforation 09/2018
1	Intestinal Obstruction (Obstruction, Intestinal) 09/2018
1	Carcinogenesis 12/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2016
1	Melanoma (Melanoma, Malignant) 01/2014

Drug/Important Bio-Agent (IBA)

8	Fluorouracil (Carac)FDA LinkGeneric 04/2024 - 11/2014
7	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 11/2014
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2024 - 11/2014
5	Leucovorin (Folinic Acid)FDA Link 04/2024 - 01/2020
5	Cetuximab (Erbitux)FDA Link 01/2021 - 11/2015
4	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2022
4	Bevacizumab (Avastin)FDA Link 02/2022 - 11/2015
3	Capecitabine (Xeloda)FDA Link 04/2024 - 06/2019
3	pembrolizumabIBA 12/2021 - 12/2019
2	B7-H1 AntigenIBA 01/2020 - 12/2019
2	histone deacetylase 3IBA 12/2018 - 01/2017
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2016 - 01/2014
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2016 - 01/2014
1	Polysaccharides (Glycans)IBA 04/2024
1	Therapeutic UsesIBA 04/2024
1	Inulin FDA Link 04/2024
1	Calcium OxalateIBA 04/2024
1	A 7 (A-7)IBA 04/2024
1	SynucleinsIBA 02/2024
1	Indicators and Reagents (Reagents)IBA 01/2024
1	Calcibiotic Root Canal SealerIBA 12/2023
1	Programmed Cell Death 1 ReceptorIBA 12/2023
1	HLA-DQB1 antigen (HLA DQB1)IBA 10/2023
1	Biomarkers (Surrogate Marker)IBA 10/2023
1	HLA-DQA1 antigen (HLA DQA1)IBA 10/2023
1	Imatinib Mesylate (Gleevec)FDA Link 02/2023
1	N-acetyltalosaminuronic acid (NAT)IBA 02/2023
1	Estazolam (ProSom)FDA LinkGeneric 07/2022
1	Palonosetron (Aloxi)FDA Link 07/2022
1	Aprepitant (Emend)FDA Link 07/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 07/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 02/2022
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2022
1	toripalimabIBA 01/2022
1	Celecoxib (Celebrex)FDA Link 01/2022
1	Axitinib (AG 013736)IBA 01/2021
1	encorafenibIBA 01/2021
1	durvalumabIBA 01/2021
1	binimetinibIBA 01/2021
1	Sunitinib (Sutent)FDA Link 01/2021
1	conatumumabIBA 10/2020
1	regorafenibIBA 10/2020
1	atezolizumabIBA 01/2020
1	IpilimumabIBA 01/2020
1	NivolumabIBA 01/2020
1	AnthracyclinesIBA 06/2019
1	Taxoids (Taxanes)IBA 06/2019
1	Carcinoembryonic AntigenIBA 11/2018
1	Cadherins (E-Cadherin)IBA 12/2017
1	MicroRNAs (MicroRNA)IBA 12/2017
1	CateninsIBA 12/2017
1	ParaffinIBA 11/2014
1	Diphosphonates (Bisphosphonates)IBA 10/2013

Therapy/Procedure

14	Drug Therapy (Chemotherapy) 01/2023 - 06/2013
12	Neoadjuvant Therapy 04/2024 - 01/2016
11	Therapeutics 12/2023 - 09/2018
3	Radiotherapy 01/2023 - 12/2019
2	Immunotherapy 10/2023 - 01/2020
2	Chemoradiotherapy 01/2023 - 01/2022
1	Adjuvant Chemotherapy 01/2020
1	Aftercare (After-Treatment) 01/2020